(26 April 2020) Human recombinant soluble ACE 2 enzyme – hrsACE2 can block early entry of SARS-CoV-2 infections in host cells
Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2 https://doi.org/10.1016/j.cell.2020.04.004 Authors report that clinical grade hrsACE2 reduced SARS-CoV-2 recovery from Vero cells by a factor of 1,000–5,000. An equivalent mouse rsACE2 had no effect. They also… Continue reading "(26 April 2020) Human recombinant soluble ACE 2 enzyme – hrsACE2 can block early entry of SARS-CoV-2 infections in host cells"